SG11201405837YA - Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid - Google Patents

Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid

Info

Publication number
SG11201405837YA
SG11201405837YA SG11201405837YA SG11201405837YA SG11201405837YA SG 11201405837Y A SG11201405837Y A SG 11201405837YA SG 11201405837Y A SG11201405837Y A SG 11201405837YA SG 11201405837Y A SG11201405837Y A SG 11201405837YA SG 11201405837Y A SG11201405837Y A SG 11201405837YA
Authority
SG
Singapore
Prior art keywords
bromobenzoyl
amino
composition containing
aqueous composition
phenylacetic acid
Prior art date
Application number
SG11201405837YA
Other languages
English (en)
Inventor
Takashi Morimoto
Hiroyuki Asada
Kyohei Takahashi
Tomoyuki Okamoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SG11201405837YA publication Critical patent/SG11201405837YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11201405837YA 2012-03-28 2013-03-28 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid SG11201405837YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (ja) 2012-03-28 2013-03-28 2-アミノ-3-(4-ブロモベンゾイル)フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
SG11201405837YA true SG11201405837YA (en) 2014-11-27

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405837YA SG11201405837YA (en) 2012-03-28 2013-03-28 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid

Country Status (9)

Country Link
JP (1) JP5922609B2 (enExample)
KR (1) KR20140139501A (enExample)
CN (1) CN104203224A (enExample)
IN (1) IN2014DN07767A (enExample)
MY (1) MY170840A (enExample)
PH (1) PH12014502171A1 (enExample)
SG (1) SG11201405837YA (enExample)
TW (1) TWI604858B (enExample)
WO (1) WO2013147000A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199854A1 (ja) * 2015-06-10 2016-12-15 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
CN111712238A (zh) * 2017-12-14 2020-09-25 参天制药株式会社 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸或其盐的滴眼剂
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
US7829544B2 (en) * 2003-11-14 2010-11-09 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
WO2009105534A2 (en) * 2008-02-21 2009-08-27 Ista Pharmaceuticals Ophthalmic nsaids as adjuvants
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
BR112013018025A2 (pt) * 2011-01-18 2020-10-27 Senju Pharmaceutical Co., Ltd composição de bromfenac líquida aquosa método para reforçar a eficácia conservante de uma solução aquosa
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
CN104203224A (zh) 2014-12-10
IN2014DN07767A (enExample) 2015-05-15
JP5922609B2 (ja) 2016-05-24
JP2013227300A (ja) 2013-11-07
MY170840A (en) 2019-09-10
TWI604858B (zh) 2017-11-11
WO2013147000A1 (ja) 2013-10-03
TW201343197A (zh) 2013-11-01
PH12014502171A1 (en) 2014-12-10
KR20140139501A (ko) 2014-12-05

Similar Documents

Publication Publication Date Title
IL277652A (en) Stable aqueous formulations of adlimumab
SG11201503646TA (en) Esterification of 2,5-furan-dicarboxylic acid
EP2850067A4 (en) Carboxylic acid compounds
SG10201607962RA (en) Artificial nucleic acid molecules
AP4063A (en) Dimethyl-benzoic acid compounds
IL235425B (en) History of lysine-glutamic acid di-peptide
SG11201600473UA (en) Amino acid derivatives
EP2838966A4 (en) AQUEOUS COATING COMPOSITION WITH IMPROVED STABILITY
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
IL235802A0 (en) A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
PT2934134T (pt) Utilizações de inalação de ácido acetilsalicílico
EP2890409A4 (en) AQUEOUS GELS DISTINGUISHING FRAGRANCE
IL239532A0 (en) Non-staining toothpaste
ZA201504658B (en) Cinnamic acid amide derivative
SG11201405837YA (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
PL2919755T3 (pl) Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy
IL238790B (en) Capsule composition of 5-amino salicylic acid
GB201303847D0 (en) Amino acid composition
TH148762B (th) อนุพันธ์ของพิร์โรลิดีน-3-อิลแอซีติก แอซิด
GB201316110D0 (en) Phenylboronic Acid
ZA201309132B (en) Device for lead acid battery formation
GB201100589D0 (en) Central heating acid neutraliser
GB201105988D0 (en) Acid formation